Abstract：Leprosy is a significant public health issue. Zhejiang province achieved the goal of eliminating leprosy in 1995，then the leprosy has been staying in a low prevalence state. Currently，the control target is elimination of leprosy harm. Zhejiang，following a series of international and domestic strategy and policy，tries to achieve the goal of elimination of leprosy harm as soon as possible by implementing leprosy suspicious symptom surveillance system，establishing control network，stabilizing control stuff and strengthening popular science propaganda. This article describes analysis the comprehensive prevention and control in Zhejiang，evaluates the control strategy and measure of leprosy elimination，and puts forward some suggestions on existing problem and control demanding，which will provide reference for future policy making.
姚强，孔文明，沈云良，吴李梅，费丽娟，胡永方，王燕敏. 浙江省低流行状态麻风防控策略[J]. 预防医学, 2018, 30(8): 757-761.
YAO Qiang，KONG Wen-ming，SHEN Yun-liang，WU Li-mei，FEI Li-juan，HU Yong-fang，WANG Yan-min. The control strategy of leprosy under a low endemic situation in Zhejiang Province. Preventive Medicine, 2018, 30(8): 757-761.
[1] REIBEL F，CAMBAU E，AUBRY A. Update on the epidemiology，diagnosis，and treatment of leprosy[J] . Med Mal Infect，2015， 45（9）：383-393. [2] Global leprosy update，2016：accelerating reduction of disease burden[J] . Wkly Epidemiol Rec，2017，92（35）：501-519. [3] 陈祥生，江澄. 1949—1997 年中国麻风流行趋势分析[J] . 疾病监测，1999，14（8）：285-288. [4] 姚敏，孔文明，吴李梅，等. 浙江省麻风治愈者生存现状的调查研究[J] . 中国预防医学杂志，2016，17（8）：593-596. [5] 沈云良，许亚平，吴李梅. 浙江省麻风病流行情况分析[J] . 中国预防医学杂志，2010，11（5）：478-480. [6] 中华人民共和国卫生部疾病预防控制局. 关于印发《全国消除麻风病危害规划（2011—2020年）》的通知[Z/OL] .（2011-09- 29）[2018-03-19] . http：//www.nhfpc.gov.cn/jkj/s3589/201109/27 f963af36af4647894c026048be96e6.shtml [7] RAO P N. Global leprosy strategy 2016-2020：Issues and concerns[J] . Indian J Dermatol Venereol Leprol，2017，83（1）：4-6. [8] 孔文明，沈云良，吴李梅，等. 浙江省麻风可疑症状监测系统实施效果评价[J] . 中国麻风皮肤病杂志，2016，32（1）：1-3. [9] 沈云良，严丽英，孔文明，等. 浙江省麻风可疑症状监测系统卫生经济学评价[J] . 中国麻风皮肤病杂志，2014，30（12）：707-709. [10] 吴李梅，沈云良，潘美儿，等. 自我护理小组促进麻风病人畸残康复的效果评价[J] . 预防医学，2017，29（1）：60-62，65. [11] RICHARDUS J H，HABBEMA J D. The impact of leprosy control on the transmission of M. leprae：is elimination being attained[J] . Lepr Rev，2007，78（4）：330-337. [12] 费丽娟，沈云良，吴李梅，等. 住村与居家麻风治愈者生存现状调查[J] . 浙江预防医学，2015，27（10）：1029-1030，1033. [13] 孔文明，严丽英，沈云良，等. 浙江省麻风治愈存活者健康状况调查[J] . 中国麻风皮肤病杂志，2014，30（6）：338-340. [14] RINALDI A. The global campaign to eliminate leprosy[J] . PLoS Med，2005，2（12）：e341. [15] ROOSTA N，BLACK D S，REA T H. A comparison of stigma among patients with leprosy in rural Tanzania and urban United States：a role for public health in dermatology[J] . Int J Dermatol，2013，52（4）：432-440. [16] BASELP，PAHAN D，MOET F J，et al. Leprosy incidence：six years follow-up of a population cohort in Bangladesh[J] . Lepr Rev，2014，85（3）：158-169. [17] BANERJEE S，SARKAR K，GUPTA S，et al. Multiplex PCR technique could be an alternative approach for early detection of leprosy among close contacts-a pilot study from India[J] . BMC Infect Dis，2010，10：252. [18] IDEMA W J，MAJER I M，PAHAN D，et al. Cost-effectiveness of a chemoprophylactic intervention with single dose rifampicin in contacts of new leprosy patients[J] . PLoS Negl Trop Dis，2010， 4（11）：e874. [19] BAKKER M I，HATTA M，KWENANG A，et al. Prevention of leprosy using rifampicin as chemoprophylaxis[J] . Am J Trop Med Hyg，2005，72（4）：443-448.
